Influence of insurance status on the postoperative outcomes of cytoreductive surgery and HIPEC.
Boateng KubiRichard NudotorNadege FackcheJulian RoweJordan M CloydAhmed AhmedTravis E GrotzKeith FournierSean P DineenJula VeerapongJoel M BaumgartnerCallisia N ClarkeSameer H PatelVikrom K DharLaura LambertDaniel E AbbottCourtney PokrzywaMustafa RaoofByrne LeeMohammad Y ZaidiShishir K MaithelFabian M JohnstonJonathan B GreerPublished in: Journal of surgical oncology (2022)
While there were differences in postoperative outcomes between the three insurance groups on univariate analysis, there was no independent association between insurance status and postoperative complications after CRS/HIPEC.
Keyphrases
- patients undergoing
- health insurance
- affordable care act
- long term care
- minimally invasive
- coronary artery bypass
- healthcare
- adipose tissue
- metabolic syndrome
- acute coronary syndrome
- coronary artery disease
- skeletal muscle
- glycemic control
- insulin resistance
- percutaneous coronary intervention
- metastatic renal cell carcinoma